Literature DB >> 7818527

Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.

A Couvineau1, P Gaudin, J J Maoret, C Rouyer-Fessard, P Nicole, M Laburthe.   

Abstract

The human VIP receptor belongs to a subfamily of G protein-coupled receptors that includes secretin, glucagon and several other receptors. We have used site-directed mutagenesis to investigate the requirement of highly conserved aspartate 68 (mutant D68G), tryptophane 73 (mutant W73G), proline 87 (mutant P87G), glycine 109 (mutant delta 109) and tryptophane 110 (mutant W110G) for the ability of the human VIP receptor to bind VIP. After transfection of mutated cDNAs in Cos-7 cells, it appeared that mutants G87P and W110G bound VIP with the same dissociation constant as the wild type receptor whereas mutants W73G, P87G and delta 109 did not bind VIP. Since all mutated receptor proteins were synthesized by Cos-7 cells (Western blot) and expressed at the plasma membrane level (immunofluorescence studies), it is concluded that the N-terminal extracellular domain of the human VIP receptor contains highly conserved amino acid residues which are essential for its intrinsic binding activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7818527     DOI: 10.1006/bbrc.1995.1034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Insulinotropic toxins as molecular probes for analysis of glucagon-likepeptide-1 receptor-mediated signal transduction in pancreatic beta-cells.

Authors:  G G Holz; C A Leech; J F Habener
Journal:  Biochimie       Date:  2000 Sep-Oct       Impact factor: 4.079

2.  Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors.

Authors:  E M Lutz; C J MacKenzie; M Johnson; K West; J A Morrow; A J Harmar; R Mitchell
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 3.  VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.

Authors:  Alain Couvineau; Marc Laburthe
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

5.  Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).

Authors:  S M Knudsen; J W Tams; J Fahrenkrug
Journal:  J Mol Neurosci       Date:  2000-06       Impact factor: 3.444

6.  Expression and fine mapping of murine vasoactive intestinal peptide receptor 1.

Authors:  B Karacay; M S O'Dorisio; K Kasow; C Hollenback; R Krahe
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

7.  Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.

Authors:  K M Braas; V May; S A Harakall; J C Hardwick; R L Parsons
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.

Authors:  G G Holz; J F Habener
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-10       Impact factor: 2.231

9.  Exploration of the endogenous agonist mechanism for activation of secretin and VPAC1 receptors using synthetic glycosylated peptides.

Authors:  Maoqing Dong; Delia I Pinon; Laurence J Miller
Journal:  J Mol Neurosci       Date:  2008-04-12       Impact factor: 3.444

10.  Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.

Authors:  Maoqing Dong; Fan Gao; Delia I Pinon; Laurence J Miller
Journal:  Mol Endocrinol       Date:  2008-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.